Habanjar Ola, Diab-Assaf Mona, Caldefie-Chezet Florence, Delort Laetitia
Université Clermont-Auvergne, INRAE, UNH, ECREIN, f-63000 Clermont-Ferrand, France.
Equipe Tumorigénèse Pharmacologie moléculaire et anticancéreuse, Faculté des Sciences II, Université libanaise Fanar, Beyrouth 1500, Liban.
Biology (Basel). 2022 Feb 21;11(2):339. doi: 10.3390/biology11020339.
Tumor metastasis is a major cause of death in cancer patients. It involves not only the intrinsic alterations within tumor cells, but also crosstalk between these cells and components of the tumor microenvironment (TME). Tumorigenesis is a complex and dynamic process, involving the following three main stages: initiation, progression, and metastasis. The transition between these stages depends on the changes within the extracellular matrix (ECM), in which tumor and stromal cells reside. This matrix, under the effect of growth factors, cytokines, and adipokines, can be morphologically altered, degraded, or reorganized. Many cancers evolve to form an immunosuppressive TME locally and create a pre-metastatic niche in other tissue sites. TME and pre-metastatic niches include myofibroblasts, immuno-inflammatory cells (macrophages), adipocytes, blood, and lymphatic vascular networks. Several studies have highlighted the adipocyte-macrophage interaction as a key driver of cancer progression and dissemination. The following two main classes of macrophages are distinguished: M1 (pro-inflammatory/anti-tumor) and M2 (anti-inflammatory/pro-tumor). These cells exhibit distinct microenvironment-dependent phenotypes that can promote or inhibit metastasis. On the other hand, obesity in cancer patients has been linked to a poor prognosis. In this regard, tumor-associated adipocytes modulate TME through the secretion of inflammatory mediators, which modulate and recruit tumor-associated macrophages (TAM). Hereby, this review describes the cellular and molecular mechanisms that link inflammation, obesity, and cancer. It provides a comprehensive overview of adipocytes and macrophages in the ECM as they control cancer initiation, progression, and invasion. In addition, it addresses the mechanisms of tumor anchoring and recruitment for M1, M2, and TAM macrophages, specifically highlighting their origin, classification, polarization, and regulatory networks, as well as their roles in the regulation of angiogenesis, invasion, metastasis, and immunosuppression, specifically highlighting the role of adipocytes in this process.
肿瘤转移是癌症患者死亡的主要原因。它不仅涉及肿瘤细胞内部的内在改变,还涉及这些细胞与肿瘤微环境(TME)成分之间的相互作用。肿瘤发生是一个复杂而动态的过程,包括以下三个主要阶段:起始、进展和转移。这些阶段之间的转变取决于细胞外基质(ECM)内的变化,肿瘤细胞和基质细胞存在于该基质中。在生长因子、细胞因子和脂肪因子的作用下,这种基质可在形态上发生改变、降解或重组。许多癌症会在局部演变成免疫抑制性TME,并在其他组织部位形成前转移微环境。TME和前转移微环境包括肌成纤维细胞、免疫炎症细胞(巨噬细胞)、脂肪细胞、血液和淋巴管网络。几项研究强调脂肪细胞与巨噬细胞的相互作用是癌症进展和扩散的关键驱动因素。巨噬细胞主要分为以下两类:M1(促炎/抗肿瘤)和M2(抗炎/促肿瘤)。这些细胞表现出不同的依赖于微环境的表型,可促进或抑制转移。另一方面,癌症患者的肥胖与预后不良有关。在这方面,肿瘤相关脂肪细胞通过分泌炎症介质来调节TME,这些炎症介质可调节并募集肿瘤相关巨噬细胞(TAM)。因此,本综述描述了将炎症、肥胖和癌症联系起来的细胞和分子机制。它全面概述了ECM中的脂肪细胞和巨噬细胞,因为它们控制着癌症的起始、进展和侵袭。此外,它还探讨了M1、M2和TAM巨噬细胞的肿瘤锚定和募集机制,特别强调了它们的起源、分类、极化和调控网络,以及它们在血管生成、侵袭、转移和免疫抑制调节中的作用,特别突出了脂肪细胞在这一过程中的作用。